Condition: Cervical Intraepithelial Neoplasia · Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
HPV vaccination has emerged as a strategy to reduce the risk of recurrence oafter excisional treatment. However, only few data are aviable. In this trial the investigators aim to assess the role of HPV vaccination in women traeted for HPV-related lesions
This description comes directly from the study's public registry record.
Giorgio Bogani, ph.d. · 651-296-9676 · giorgiobogani@yahoo.it
Always discuss trial participation with your own doctor first.
| Fondazione IRCCS Istituto Nazionale dei Tumori | Milan, Lombardy, Italy | Recruiting |
| Fondazione IRCCS Istituto Nazionale dei Tumori | Milan, Lombardy, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06611020